Progeroid laminopathies are characterized by the abnormal processing of lamin A, the appearance of misshapen nuclei, and the accumulation and persistence of DNA damage. In the present article, I consider the contribution of defective DNA damage pathways to the pathology of progeroid laminopathies. Defects in DNA repair pathways appear to be caused by a combination of factors. These include abnormal epigenetic modifications of chromatin that are required to recruit DNA repair pathways to sites of DNA damage, abnormal recruitment of DNA excision repair proteins to sites of DNA double-strand breaks, and unrepairable ROS (reactive oxygen species)-induced DNA damage. At least two of these defective processes offer the potential for novel therapeutic approaches.
The progeroid laminopathies and prelamin A toxicity
The progeroid laminopathies include HGPS (HutchinsonGilford progeria syndrome), atypical Werner's syndrome, MAD (mandibuloacral dysplasia) and RD (restrictive dermopathy) [1] . All of these diseases have been linked to abnormal post-translational processing of prelamin A, which promotes nuclear shape abnormalities and cellular toxicity [2] [3] [4] [5] . The initial post-translational processing of lamin A is now well-characterized. Lamin A is first translated as a precursor molecule termed prelamin A that possesses a Cterminal motif, CaaX (where a is an aliphatic residue), which is a receptor site for protein farnesylation and methylation. Initially, the cysteine residue is farnesylated before the final three amino acids are proteolytically cleaved. This is followed by methylation of the now C-terminal cysteine residue before the partially processed prelamin A is translocated to the INM (inner nuclear membrane). Once at the INM, the final 15 amino acids are cleaved by the ZmpSte24 (zinc metallopeptidase Ste24 homologue) protease to generate mature lamin A [3, 6] . A majority (∼ 80%) of mutations giving rise to HGPS are caused by silent mutations in exon 11 of LMNA that activates a cryptic splice site and permits synthesis of an alternatively splice variant of prelamin A, termed progerin, which lacks the ZmpSte24 cleavage site and consequently cannot undergo the final processing step. This in turn means that progerin is permanently farnesylated [7, 8] . The representation of progerin in fibroblasts from HGPS Key words: DNA damage response, Hutchinson-Gilford progeria syndrome (HGPS), lamin, laminopathy, progeria, reactive oxygen species (ROS). Abbreviations used: ATM, ataxia telangiectasia mutated; ATR, ATM-and Rad3-related; 53BP1, p53-binding protein 1; DDR, DNA damage response; DSB, double-strand break; FC-prelamin A, prelamin A with farnesylated cysteine residue; FTI, farnesyltransferase inhibitor; HGPS, Hutchinson-Gilford progeria syndrome; HP1, heterochromatin protein 1; INM, inner nuclear membrane; MAD, mandibuloacral dysplasia; MEF, mouse embryonic fibroblast; NAC, Nacetylcysteine; NuRD, nucleosome remodelling and deacetylation; RBBP, retinoblastoma-binding protein; RD, restrictive dermopathy; ROS, reactive oxygen species; siRNA, small interfering RNA; XPA, xeroderma pigmentosum group A; ZmpSte24, zinc metallopeptidase Ste24 homologue. 1 email c.j.hutchison@durham.ac.uk patients increases with increasing passage number [9] and this is thought to increase its toxic effects. In RD and MAD, as well as in some cases of HGPS, the diseases are caused by homozygous mutations in a conserved region of the gene encoding the ZmpSte24 protease, and in fibroblasts from these patients, the disease is caused by abnormal processing of prelamin A, leading to the accumulation of a form of prelamin A that retains the farnesylated cysteine residue (FCprelamin A) [10] [11] [12] . Some forms of HGPS (non-classical HGPS) as well as atypical Werner's syndrome are caused by mutations in exons of LMNA encoding the rod domain of lamins A and C [1] and do not give rise to splice site variants, whereas other mutations occur in the BANF1 gene [encoding the chromatin protein BAF (barrier to autointegration factor 1)] [13] , suggesting that laminopathy progerias do not necessarily all arise through the accumulation of farnesylated forms of lamin A.
Despite reports of non-classical forms of HGPS, therapeutic approaches have centred on the use of drugs that inhibit the farnesylation of both progerin and prelamin A. These include the use of FTIs (farnesyltransferase inhibitors) as a direct tool to inhibit farnesylation [2, 4, 5] or a combination of aminobisphosphonates and statins, which act indirectly by preventing the synthesis of precursors of farnesyl and geranyl residues [14] . Both types of treatment do extend lifespan in mouse models of HGPS [14] and are currently being used in clinical trials.
DDR (DNA damage response) in progeroid laminopathies
As stated above, the most obvious morphological feature of the progeroid laminopathies is the appearance of misshapen (or dysmorphic) nuclei in cells obtained from patients or in cells that express progerin ectopically [9] . The presence of dysmorphic nuclei can be ameliorated by growing cells in media containing FTIs [2, 4, 5] . Another feature of fibroblasts from progeroid laminopathy patients is the accumulation of unrepaired DNA damage [15] [16] [17] and accelerated telomere attrition [18, 19] . The accumulation of unrepaired DNA damage activates a checkpoint response that is characterized by phosphorylation of both the ATM (ataxia telangiectasia mutated) and ATR (ATM-and Rad3-related) checkpoint kinases. Activation of checkpoint responses seems to underlie the slow growth of HGPS fibroblasts in culture, since siRNA (small interfering RNA) knockdown of ATM and ATR in these cells restores replicative capacity [20] . In stark contrast with nuclear shape abnormalities, accumulation of unrepaired DNA damage is not reversed by treatment with FTIs [20] and this finding is consistent with studies showing that the accumulation of unfarnesylated forms of progerin in mice still promotes aging phenotypes [21] , whereas treatment of Caenorhabditis elegans with FTIs limits the accumulation of dysmophic nuclei, without extending lifespan [22] . These findings argue strongly that processes other those promoting the formation of dysmorphic nuclei account for the aging phenotypes in laminopathy progerias and has led to a number of investigations into the causes and effects of the accumulation of unrepairable DNA damage in these diseases.
The first study revealing the increased sensitivity to ionizing radiation and genome instability in a mouse model of HGPS and fibroblasts from HGPS patients demonstrated that the DDR was impaired and that this was characterized by delayed recruitment of DNA damage proteins, including 53BP1 (p53-binding protein 1) and Rad50 to sites of DNA damage [15] . The impaired DDR was correlated with activation of p53-response pathways, although, curiously, this occurred in the absence of increased levels of p53 or p53 phosphorylation [23] . DDRs are characterized by epigenetic modification of chromosomes, including the accumulation of the phosphorylated form of a histone H2A variant H2AX at sites of DNA DSBs (double-strand breaks) [24] and methylation of histone H3 and histone H4 [25, 26] . A hallmark of fibroblasts from progeriod laminopathy patients is the persistence of H2AX foci [15] , altered methylation of H3 and H4 and down-regulation of HP1 (heterochromatin protein 1) [27, 28] , which are all predicted to lead to a loss of heterochromatin. The persistence of H2AX foci is indicative of an accumulation of unrepaired DSBs. However, there is now strong evidence that this is underpinned by altered H3 methylation. The NuRD (nucleosome remodelling and deacetylation) complex is a key regulator of histone methylation [29] . Chromatin proteins RBBP (retinoblastoma-binding protein) 4 and its paralogue RBBP7 are both components of the NuRD complex and bind to the region of the lamin A tail domain, which is lacking in progerin. The levels of both RBBP4 and RBBP7 are reduced in HGPS fibroblasts compared with agematched control fibroblasts, and this loss is dependent upon the presence of progerin. Interestingly, loss of RBBP4 and RBBP7 precedes the accumulation of persistent H2AX foci, and siRNA knockdown of RBBP4 and RBBP7 in normal fibroblasts leads to decreased H3 methylation followed by the accumulation of H2AX foci. Knockdown of other components of the NuRD complex also promote the accumulation of unrepaired DSBs [30] . In a more recent study, hypoacetylation of H4 was observed in fibroblasts from a ZmpSte24 − / − mouse. Hypoacetylation of H4 was linked to loss of nuclear matrix association of the histone acetyltransferase Mof. Importantly, overexpression of Mof in ZmpSte24 − / − fibroblasts or treatment of the cells with a histone deacetylase inhibitor promoted the recruitment of DNA repair proteins to sites of DNA damage and significantly decreased the rate of entry into a senescent state [31] . Both of these studies therefore imply that the impairment of the DDR, in the presence of either progerin or FC-prelamin A, arises from defects in chromatin-remodelling steps that precede the recruitment of DNA damage proteins to sites of DNA repair.
Impairment of DDR in fibroblasts from HGPS and RD patients appears to be also related to incorrect recognition of types of DNA damage. As stated above, DSBs induced by ionizing radiation in HGPS fibroblasts are characterized by impaired recruitment of the DNA repair proteins Rad50 and Rad51 [31] . Both HGPS and RD fibroblasts accumulate DSBs during passage in culture, even in the absence of mutagenesis, and therefore carry a mutational load. Interestingly, when treated with genotoxic agents such as camptothecin or etoposide, newly induced DSBs can be repaired efficiently in both HGPS and RD fibroblasts [32, 33] . In contrast, the accumulated load of DNA damage remains unrepaired. These sites fail to recruit Rad50 and Rad51, but instead recruit the DNA excision repair protein XPA (xeroderma pigmentosum group A). Importantly, siRNA knockdown of XPA in HGPS and RD fibroblasts partially restores the ability of these cells to undergo DNA repair, implying that the presence of XPA at sites of DSBs is involved in the failure to recruit DSB proteins to those same sites [32] .
In a separate study, loss of stability of the DNA repair protein 53BP1 has been implicated in telomere erosion and persistent DSBs at telomeric DNA. This study utilized MEFs (mouse embryonic fibroblasts) from an Lmna − / − mouse. In these MEFs, telomeric DNA was abnormally distributed in the interphase nucleus being clustered towards the nuclear periphery (although not located at the nuclear envelope) compared with wild-type MEFs, in which telomeres were distributed throughout the nucleus. This abnormal distribution of telomeric DNA was correlated with a modest, but significant, shortening of telomere length, but highly significantly impaired H4 methylation and accumulation of H2AX in telomeric chromatin [34] . Telomeric DNA damage is repaired by NHEJ (non-homologous end-joining), which is mediated by the DNA repair protein 53BP1 [35] . Consistent, with this finding, the overall levels of 53BP1 were reduced in Lmna − / − MEFs [34] .
ROS (reactive oxygen species) and persistent DNA damage in HGPS and RD
Recent studies have reported on the increased sensitivity of fibroblasts from progeria patients to oxidative stress [36] .
Moreover, progerin has also been reported to promote the accumulation of oxidized proteins in fibroblasts [37] . ROS generation and imbalance is a major cause of DNA damage [38] and could underlie the accumulation and persistence of DSBs in HGPS and RD fibroblasts with increasing age in culture. With this in mind, ROS levels and ROS sensitivity in fibroblasts from HGPS and RD patients were investigated. Significantly higher basal levels of ROS, as well as increased sensitivity to ROS stimuli, were reported. Both of these features could be ameliorated with a commonly used ROS scavenger NAC (N-acetylcysteine). ROS stimulation led to DNA damage, which was only partially repaired and therefore increased the load of DSBs in HGPS and RD fibroblasts. Interestingly, treatment of cells with NAC, before ROS stimulation, permitted repair of all DSBs. Moreover, growth of HGPS and RD fibroblasts in the presence of NAC also significantly reduced the basal levels of DSBs. This finding implies that the elevated basal levels of ROS in these cells is the cause of the persistent DNA damage [33] .
Links to normal aging
ROS generation and the accumulation of persistent DNA damage have both been linked to cellular and organismal aging [39, 40] . Expression of progerin and prelamin A have also been linked to cellular senescence and aging in normal individuals [27, 41] . It is therefore important to understand whether the mechanisms underlying the impaired DDR in laminopathy progerias also underlie the accumulation of persistent DNA damage in normal aging. Components of the NuRD complex, including RBBP4, RBBP7 and HP1, are all depleted in fibroblasts from very old individuals relative to fibroblasts from very young individuals, implying that at least one of the chromatin-remodelling pathways necessary for efficient DNA repair loses efficiency with increasing age [30] . In contrast, fibroblasts from very old individuals do not display increased basal levels of ROS or increased ROS sensitivity when compared with fibroblasts from very young individuals. Moreover, repair of ROS-induced DSBs is very efficient in the same cells [33] . Thus the DNA repair defects in laminopathy progeroid syndromes appear to be only a partial phenocopy of normal aging.
New therapeutic targets
At least two of the DNA damage defects in progeroid laminopathies appear to offer novel targets for pharmacological intervention. At present, the most successful therapies for existing patients is a combination of aminobisphosphonates and statins [14] . However, ZmpSte24 − / − mice that were provided with a histone deacetylase inhibitor in their drinking water displayed weight gain, increased bone density and increased lifespan compared with untreated littermates [31] . Similarly, when grown in the presence of NAC, fibroblasts from HGPS and RD patients displayed normal growth kinetics and increased longevity [33] . Thus a combination of therapeutic approaches, which includes targets in DNA repair pathways, might offer significant improvements in quality of life for patients with progeroid laminopathies.
